VIRGINIA RETIREMENT SYSTEMS ET Al Sells 29,050 Shares of Pediatrix Medical Group, Inc. $MD

VIRGINIA RETIREMENT SYSTEMS ET Al cut its position in Pediatrix Medical Group, Inc. (NYSE:MD) by 43.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 38,050 shares of the company’s stock after selling 29,050 shares during the quarter. VIRGINIA RETIREMENT SYSTEMS ET Al’s holdings in Pediatrix Medical Group were worth $814,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Smartleaf Asset Management LLC raised its position in shares of Pediatrix Medical Group by 10.6% in the third quarter. Smartleaf Asset Management LLC now owns 6,250 shares of the company’s stock valued at $101,000 after purchasing an additional 601 shares during the period. PNC Financial Services Group Inc. lifted its holdings in Pediatrix Medical Group by 4.5% during the 3rd quarter. PNC Financial Services Group Inc. now owns 14,525 shares of the company’s stock worth $243,000 after purchasing an additional 631 shares in the last quarter. Gotham Asset Management LLC raised its position in shares of Pediatrix Medical Group by 0.6% in the third quarter. Gotham Asset Management LLC now owns 116,093 shares of the company’s stock worth $1,945,000 after buying an additional 724 shares in the last quarter. Amalgamated Bank raised its position in shares of Pediatrix Medical Group by 3.5% in the third quarter. Amalgamated Bank now owns 24,891 shares of the company’s stock worth $417,000 after buying an additional 831 shares in the last quarter. Finally, Verition Fund Management LLC raised its position in shares of Pediatrix Medical Group by 4.4% in the third quarter. Verition Fund Management LLC now owns 25,408 shares of the company’s stock worth $426,000 after buying an additional 1,066 shares in the last quarter. Institutional investors own 97.71% of the company’s stock.

Wall Street Analysts Forecast Growth

MD has been the topic of a number of research analyst reports. UBS Group increased their price target on shares of Pediatrix Medical Group from $22.00 to $25.00 and gave the stock a “neutral” rating in a report on Tuesday, May 12th. Truist Financial increased their price target on shares of Pediatrix Medical Group from $21.00 to $23.00 and gave the stock a “hold” rating in a report on Monday, April 13th. Weiss Ratings reissued a “hold (c+)” rating on shares of Pediatrix Medical Group in a report on Friday, March 27th. Mizuho set a $24.00 price target on shares of Pediatrix Medical Group in a report on Friday, May 8th. Finally, Deutsche Bank Aktiengesellschaft set a $19.00 price target on shares of Pediatrix Medical Group in a report on Friday, February 20th. One investment analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $22.50.

Pediatrix Medical Group Price Performance

MD stock opened at $22.43 on Monday. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.33 and a current ratio of 1.33. Pediatrix Medical Group, Inc. has a 52 week low of $11.84 and a 52 week high of $24.99. The firm’s fifty day moving average is $21.54 and its 200 day moving average is $21.59. The firm has a market cap of $1.84 billion, a P/E ratio of 10.89 and a beta of 0.70.

Pediatrix Medical Group (NYSE:MD) last released its earnings results on Tuesday, May 5th. The company reported $0.44 EPS for the quarter, beating the consensus estimate of $0.37 by $0.07. Pediatrix Medical Group had a net margin of 9.02% and a return on equity of 19.94%. The company had revenue of $476.20 million for the quarter, compared to analyst estimates of $465.83 million. During the same quarter last year, the firm earned $0.33 EPS. The firm’s quarterly revenue was up 3.9% compared to the same quarter last year. Research analysts predict that Pediatrix Medical Group, Inc. will post 2.08 earnings per share for the current year.

Insiders Place Their Bets

In other Pediatrix Medical Group news, Director Shirley A. Weis sold 36,028 shares of the stock in a transaction on Wednesday, May 13th. The shares were sold at an average price of $23.75, for a total transaction of $855,665.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.80% of the stock is owned by insiders.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.